Drugmakers are developing drugs that target different neurotransmitter systems, providing effective, long-acting treatments with fewer side effects and improved adherence
Adrian Possumato and Chris Gilmor from Sanner of America discuss the practical implementation of QbD and how these strategies are driving innovation in oral dose packaging design...
Stevanato Group's Alessandro Morandotti, Daniel Martinez and Federico Scattolin discuss the latest advancements in containment and inspection technologies
From drug containment solutions to modern manufacturing technologies, the latest advancements are setting new standards for what’s possible in health care